Meet Brandi — one of our incredible alopecia areata patients who’s been using her voice to spread awareness nationwide. In this interview, she shares her journey with alopecia, the challenges it brings, and how treatment completely changed her life.
What many don’t see behind the scenes is how clinical trials made this possible. Brandi participated in one of our trials for a JAK inhibitor that is now FDA approved as Leqselvi™ (ritlecitinib) — giving hope and real options to patients living with alopecia areata.
Stories like Brandi’s remind us why clinical research matters. Every trial participant helps move science forward and makes new treatments possible.